Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 1 (TLR1) is a member of the toll-like receptor (TLR) family, which are pattern recognition receptors (PRRs) central to the innate immune system. TLR1 primarily recognizes bacterial lipoproteins and glycolipids, typically in complex with TLR2. It is a cell surface receptor expressed on sentinel cells such as macrophages and dendritic cells. Upon ligand binding and dimerization with TLR2, the intracellular TIR domains recruit adaptor proteins, primarily MyD88, to initiate downstream signaling cascades leading to activation of transcription factors such as NF-kB or AP-1. This results in upregulation of pro-inflammatory cytokines and other mediators that coordinate innate immunity responses against pathogens.
TLR1 agonists stimulate the receptor, leading to activation of NF-kB and AP-1, resulting in upregulation of pro-inflammatory cytokines and other mediators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 1 (TLR1).